Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bio-Rad and Bruker launch biomarker purification product

This article was originally published in Clinica

Executive Summary

Bio-Rad Laboratories and Bruker have launched the Lucid ID Access Pack, a device to help purify and identify biomarkers, in the US and Europe. The pack is the first for use with the Lucid Proteomics System, a joint venture from the two companies. It is designed to work with Bruker's ultrafleXtreme MALDI-TOF/TOF mass spectrometer, which the firm launched in April. The Lucid Proteomics System is the only device to combine both "top-down" and "bottom-up" approaches for biomarker discovery, the companies claim. The top-down approach enables the discovery of proteins under 30kDa, and the bottom-down method is better for proteins with higher masses – combining both allows the system to cover the whole spectrum of biomarkers.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044005

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel